Next Quarterly Earnings
Tuesday, August 4, 2026
CW 32
Pre-Market
In 30 days
Rhythm Pharmaceuticals is a US-based biopharmaceutical company focused on developing and commercializing medicines for rare genetic diseases of obesity. The company is committed to advancing innovative therapies designed to improve the quality of life for patients worldwide affected by these conditions.